0 Commentaires
0 Parts
33 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
- Connectez-vous pour aimer, partager et commenter!
- Global Bronchiectasis Drugs Market Is Estimated To Witness High Growth Owing To Rising Prevalence of Chronic Respiratory Diseases and Increasing R&D InvestmentsSWOT Analysis:Strength: The bronchiectasis drugs market is expected to grow at a CAGR of 10% over the forecast period, driven by an increasing prevalence of bronchiectasis and the rising geriatric population. Additionally, the market is supported by advancements in drug development and the introduction of innovative therapies.Weakness: One potential weakness in the bronchiectasis drugs market...0 Commentaires 0 Parts 1094 Vue 0 Aperçu
- Global Decongestant Market Is Estimated To Witness High Growth Owing To Increasing Prevalence of Respiratory Disorders & Rising Demand for Over-the-Counter DrugsThe global decongestant market is estimated to be valued at US$14.78 billion in 2023 and is expected to exhibit a CAGR of 6.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:Decongestants are drugs used to relieve nasal congestion caused by cold, allergies, sinusitis, and other respiratory disorders. These drugs are...0 Commentaires 0 Parts 1047 Vue 0 Aperçu
- Pulmonary Drugs Market Growth Accelerated by Increasing Prevalence of Respiratory DiseasesPulmonary drugs are medications used to treat respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and acute respiratory distress syndrome. These drugs help improve lung function, relieve symptoms, and prevent exacerbations of lung conditions. The increasing prevalence of respiratory diseases due to air pollution, smoking, and aging population has augmented the...0 Commentaires 0 Parts 757 Vue 0 Aperçu
- Pulmonary Drugs Market Is Estimated To Witness High Growth Owing To Rising Prevalence Of Respiratory DiseasesPulmonary drugs refers to medicines used for the treatment of various respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and pulmonary hypertension. These drugs are administered through inhalations via metered-dose inhalers, dry powder inhalers, and nebulizers. The global pulmonary drugs market offers a wide range of medications including bronchodilators,...0 Commentaires 0 Parts 837 Vue 0 Aperçu
- Respiratory Antiviral Drugs Market Size, Share, Demand, Future Growth, Challenges and Competitive AnalysisRespiratory Antiviral Drugs Market research report has been prepared with the systematic gathering and evaluation of market information for industry which is presented in a form that explains various facts and figures to the business. A comprehensive analysis of the market structure along with the forecast of the various segments and sub-segments of the market have been delivered through...0 Commentaires 0 Parts 339 Vue 0 Aperçu
- Respiratory Therapeutics is the Largest Segment Driving the Growth of Pulmonary Drugs MarketSWOT Analysis Strength: Wide range of drugs available for treatment of pulmonary diseases. Growing awareness regarding respiratory illnesses.Weakness: High costs associated with development of novel treatment regimens. Side effects of few drugs discourage compliance. Opportunity: Rising pollution and urbanization in developing nations present an opportunity. Untapped rural markets yet to adopt...0 Commentaires 0 Parts 1087 Vue 0 Aperçu
- The Global Inhalable Drugs Market Is Driven By Increasing Prevalence Of Respiratory DiseasesThe Global Inhalable Drugs Market is primarily comprises of pharmaceutical products that can be inhaled through mouth or nasal route. Inhalable drugs are mainly used for the treatment of respiratory diseases such as asthma, COPD and cystic fibrosis. Common inhalable drugs include corticosteroids, bronchodilators and vaccines. These drugs provide localized and direct delivery of...0 Commentaires 0 Parts 258 Vue 0 Aperçu
- The Global Pulmonary Drugs Market is driven by increasing prevalence of respiratory diseasesThe global pulmonary drugs market comprises drugs used for the treatment of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, idiopathic pulmonary fibrosis, and acute respiratory distress syndrome. Some common pulmonary drugs include bronchodilators, anti-inflammatory drugs, monoclonal antibodies, anti-infective agents, and others. These drugs...0 Commentaires 0 Parts 650 Vue 0 Aperçu